期刊文献+

雷公藤多甙片联合地氯雷他定治疗慢性特发性荨麻疹的临床疗效 被引量:4

下载PDF
导出
摘要 目的针对慢性特发性荨麻疹(CIU)的药物治疗展开讨论,重点分析地氯雷他定配伍使用雷公藤多甙片的药效。方法收集用药对象(2010年12月至2012年1月),分组治疗106例CIU病例,讨论组对随机选择且自愿服药的53例病例使用地氯雷他定配伍雷公藤多甙片,参考组对其他53例病例使用地氯雷他定,相同药物的用法用量均相同,疗程均为1个月,统计有效性、生活质量合格率(睡眠、运动)和复发百分比。结果讨论组的有效性为94.3%,参考组为79.2%,讨论组高于参考组(P<0.05),差异性满足统计学要求;讨论组的生活质量合格率优于参考组(P<0.05),差异性满足统计学要求;讨论组的复发百分比为5.7%,参考组为22.6%,讨论组低于参考组(P<0.05),差异性满足统计学要求。结论针对CIU病例使用地氯雷他定配伍雷公藤多甙片的用药方案能够提高药物的有效性,降低停药复发可能性。
作者 余南生
出处 《中国医药指南》 2012年第18期630-631,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献37

  • 1[1]Henz. The pharmacologic profile of desloratadine:a review[J]. Allergy,2001,56(1) :7- 13.
  • 2[2]Anthes J, Richard C, West RE, et al. Functional characterization of desloratadine and other antihistamines in human H1receptors[ J ]. Allergy, 2000,55 (Supple63): S279.
  • 3[3]Kreutner W, Hey JA, Anthes J, et al. Preclinical pharmacology of desloratadine,a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, andantiallergic effects[J]. Arzneimittelforschung, 2000,50(2): 345 - 352.
  • 4[4]Kreutner W, Hey JA, Anthes J, et al. Preclinical studies of desloratadine, a non-sedating, selective histamine H1 receptor antagonist with antiallergic activity[J ]. Allergy, 2000,55 (Supple63): 278.
  • 5[5]Ring J, Hein R, Gauger A, et al. Once-daily desloratadine improves the signs and symtoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study[J ]. Int J Dermatol, 2001,40 ( 1 ): 72- 76.
  • 6[6]Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine[J] .J Allergy Clin Immunol,2001,107(4) :751 - 762.
  • 7[7]McClellan K, Jarvis B. Desloratadine [J ]. Drugs, 2001,61 (6): 789 -796.
  • 8[8]Barechi ME, Casciano CN, Johnson WW, et al. In vitro characterization of the inhibition profile of loratadine[ J ]. Drug Metab Dispos, 2001,29(9): 1173 - 1175.
  • 9Greaves M. Chronic urticaria[J]. J Allergy Clin Immunol, 2000,105(4): 664-672.
  • 10Finlay AY, Khan GK.Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use [J]. Clin Exp Dermatol, 1994, 19(3): 210-216.

共引文献116

同被引文献75

  • 1刘勇.雷公藤多甙片联合地氯雷他定治疗慢性特发性荨麻疹的临床疗效观察[J].当代医药论丛,2014,12(1):299-300. 被引量:5
  • 2向明,张程亮.雷公藤免疫抑制作用研究进展[J].中草药,2005,36(3):458-461. 被引量:34
  • 3黄真,毛庆秋.雷公藤多甙的临床应用、不良反应及预防[J].药品评价,2005,2(2):125-128. 被引量:43
  • 4裴淑丽.血塞通注射液治疗小儿过敏性紫癜疗效观察[J].中国医药,2006,1(4):251-251. 被引量:3
  • 5ZuberbierT, AseroR, Bindslev-Jensen C, etal.EAACIIGA(2)LENI EDF IW AO guideline: definition, classification anddiagnosis of urticaria[J] . Allergy ,2009 ,64( 10) : 1417 -1426.
  • 6Kaplan A, Greaves M. Pathogenesis of chronic urticaria[J] . Clin Exp Allergy ,2009 ,39( 6) : 777 -787.
  • 7Vahid S, Masoud M, Asghar A, et al. Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with chronic idiopathic urticaria for detection of antibody against IgE or IgE receptor (FcBRla)[J]. IranJ Allergy Asthma Immunol,2011, 10 (2) :111 -117.
  • 8Maurer M, Weller K, Bindslev-Jensen C. et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2 LEN task force report[J] . Allergy , 2011,66(3) :317 -330.
  • 9Staubach P, Onnen K, Vonend A, et al. Autologous whole blood injec?tions to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial[l]. Dermatology,2006,212 (2) : 150 -159.
  • 10Kessel A, Helou W, Bamberger E, et al. Elevated serum total IgE-ot potential marker for severe chronic urticaria[J] . Int Arch Allergy Im?munol,2010,153(3) :288 -293.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部